Maintain existing LRCX exposure with no fresh capital deployment and no trim
Hold LRCX with no new capital deployment and no trim, anchored to the 8/26 binding reflection demonstrating that token trims on this structural-bid profile (200 SMA $257, $2.28B deferred revenue rising, 65% ROE, smart-money accumulation) systematically underperform passive Hold. The execution framework tightens the prior Hold's error: compress the working stop to $258 daily close with thesis invalidation at $252 weekly close on 200 SMA break, correcting the $270-275 buffer that caused -5.0% slow-motion bleed. Re-engagement requires either a defended 200 SMA test with RSI divergence/volume confirmation or a clean 10 EMA reclaim at $313 on >50M shares with RSI >50 and positive MACD histogram. Size at ≤2-3% NAV risk-adjusted for Beta 1.865, with optional modest put protection (1-2% NAV allocation to $260-270 puts through Q1 FY27 print) given 89% Polymarket no-cut odds. Scenario asymmetry reinforces Hold: bull case +15%/+47%, base case -18%, bear case -47%. The structural setup remains elite (65% ROE, 37.4% operating margins, +15% QoQ revenue acceleration) but multiple compression risk in a 4.5% Fed Funds regime with 26x forward P/E justifies maintaining rather than adding exposure.
| Position | Action |
|---|---|
| Beta 1.865 | ≤2-3% NAV risk-adjusted position size |
| Modest put protection through Q1 FY27 print (late October/early November) | 1-2% NAV allocation to $260-270 puts with 60-90 day expiry for defined tail-risk insurance |
Lam Research's 31% pullback is healthy mean reversion inside a +211.75% annual uptrend, not a structural breakdown—the business is accelerating with Q4 FY26 revenue of $6.72B (+15% QoQ), 37.4% operating margins, and 65% ROE, while forward P/E of 26.1x for ~50% EPS growth and $3.85B in buybacks make this a coiled spring, not a falling knife.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 44.29 | neutral |
| MACD Line | -2.38 | bearish |
| MACD Signal | -2.02 | bearish |
| MACD Histogram | -0.37 | bearish |
| Bollinger Bands Middle | $315.57 | neutral |
| Bollinger Bands Upper | $340.16 | neutral |
| Bollinger Bands Lower | $290.98 | bullish |
| ATR (14) | $18.35 | bearish |
| VWMA (20-period) | ~$319.38 | bearish |
| 10 EMA | $313.43 | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Clean 10 EMA reclaim at $313 on >50M shares with RSI >50 and positive MACD histogram
Then: Re-engage long exposure
↩ rebuts: “Bear's use of RSI (44.29), MACD bearish cross, and VWMA to confirm broken trend”
EV: +$347 (15% upside from $301 at 30x multiple re-rating on FY27 EPS of ~$11.56) · concedes: Grants that the trend has 'flipped from bullish to corrective' (but not bearish); Agrees VWMA shows volume-weighted selling pressure; Agrees MACD momentum has rolled over; Agrees 200 SMA is the line that defines bull vs. bear market
LRCX is a cyclical peak stock at a cyclical peak multiple with no margin of safety, trading 15% above its 200 SMA support with a Beta of 1.865 in a hawkish macro environment, making it a high-risk entry point with asymmetric downside rather than the asymmetric upside the bull claims.
EV: -18% to -47% downside scenarios · concedes: LRCX will probably be a great stock to own again eventually; The fundamentals will still be there in 3-6 months; 200 SMA at $257.11 provides a reference support level
→ vs conservative: Using Fed rate expectations (89% probability of no cuts in 2026) as a bearish catalyst is lazy analysis for a company whose customers (TSMC, Samsung, SK Hynix, Micron) are building $20B fabs and don't cancel capex based on rates—they cancel based on AI demand inflections. LRCX is not a duration play and its order book is locked 18 months in advance.
→ vs conservative: Fixating on lagging indicators (MACD bearish cross, RSI at 44, price below 10 EMA and 50 SMA) means waiting for confirmation after smart money has already positioned. RSI at 44 without oversold print in a 31% drawdown is institutional accumulation, not capitulation.
→ vs conservative: Reading the balance sheet like 2008 is inappropriate when receivables growth reflects shipping 15% more quarter-over-quarter, not customer inability to pay. The conservative analyst cannot distinguish between growth-driven and credit-risk-driven receivables increases.
→ vs neutral: The HOLD recommendation requires being right twice—right not to sell and right about re-entry timing. The proposed entry triggers at $257 or $313 on volume will result in chasing 10-20% higher fills, missing the move entirely rather than capturing it.
→ vs neutral: If the stock reaches $257 at the 200 SMA, that would represent a 15% further drawdown and signal something fundamental broke in the thesis, not a buying opportunity. The entire secular case hinges on $255-$257 holding as support.
| 50 SMA | $331.20 | bearish |
| 200 SMA | $257.11 | bullish |
Support: 290.98 · 257.11 · 252.35 | Resistance: 313.43 · 331.2 · 340.16
LRCX underwent a dramatic regime change, falling 31.2% from $438.50 to $301.49 in two months. The stock trades below the 10 EMA ($313.43) and 50 SMA ($331.20) but remains above the 200 SMA ($257.11), indicating a correction within a structural uptrend rather than a full trend reversal. RSI (44.29) did not reach oversold during the selloff, suggesting persistent institutional selling without capitulation. MACD is in early bearish phase with negative histogram widening. ATR ($18.35) signals elevated volatility with 6% daily move potential. Critical support sits at $290.98 (Bollinger lower band) and $257.11 (200 SMA); losing the 200 SMA would signal a structural bear market. Resistance at $313.43 requires reclaim on volume for any near-term bounce thesis. The final transaction proposal is HOLD — existing holders should tighten stops while new entrants wait for confirmation.
Market Cap
$377.26B
Beta
1.865
P/E (TTM)
52.25x
Forward P/E
26.09x
PEG Ratio
1.48
Price/Book
30.25x
EPS (TTM)
$5.77
Forward EPS
$11.56
Dividend Yield
0.44%
52-Week High
$438.50
52-Week Low
$94.11
50-Day MA
$331.21
200-Day MA
$257.34
Revenue (TTM)
$23.23B
Gross Margin (TTM)
~50.5%
Operating Margin (TTM)
37.4%
Net Income (TTM)
$7.27B
Net Margin
31.3%
ROE
65.1%
ROA
22.8%
Current Ratio
2.63
Debt/Equity
33.05%
Cash & Equivalents
$5.58B
Net Cash Position
$1.86B
Total Assets
$23.53B
Total Stockholders' Equity
$12.47B
FY26 Revenue
$23.23B
FY26 Operating Income
$8.20B
FY26 Net Income
$7.27B
FY26 Diluted EPS
$5.76
FY26 EBITDA
$8.86B
FY26 Free Cash Flow
$4.89B
FY26 CapEx
$966M
FY26 Buybacks
$3.85B
FY26 Dividends
$1.27B
Diluted Shares Outstanding
~1.256B
Book Value per Share
$9.97
Strengths
Concerns
Lam Research Corporation delivered strong FY2026 results with revenue of $23.23B (+26% YoY) and net income of $7.27B, driven by AI/HBM memory build-out and advanced packaging demand, with operating margins expanding to 37.4% TTM. The company maintains a fortress balance sheet with $5.58B in cash, a net cash position of ~$1.86B, and returned approximately $5.88B to shareholders in FY26 through dividends and buybacks. Despite a premium trailing P/E of 52.3x (forward 26.1x), the valuation is supported by expected ~100% EPS growth and the company's critical role in semiconductor fabrication equipment for AI accelerators, though risks include high cyclicality, geopolitical headwinds from China export controls, and elevated volatility (Beta 1.865).
Macro: Hawkish macro regime with 89% probability of zero Fed rate cuts in 2026 per Polymarket prediction markets, up 2.2 percentage points over the prior week. Markets are now pricing actual rate-hike expectations, reinforcing 'higher for longer' dynamics — a structural headwind for long-duration growth multiples in the technology sector. Renewed Middle East military strikes are driving safe-haven USD flows and adding geopolitical risk premium. Semiconductor stocks led broader index weakness in the S&P 500 and Nasdaq, with sector-level selling pressuring equipment names broadly. Note: FRED-sourced macro indicators (Fed Funds, 10Y Treasury, CPI) were unavailable due to missing vendor API key — conclusions anchored in prediction markets and news flow.